Longeveron to Present at the Emerging Growth Virtual
MIAMI, Feb. 14, 2025 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the Emerging Growth Virtual Conference taking place February 18-19, 2025. Details for the Company’s presentation: Date: February 19, 2025 … Read more